127 related articles for article (PubMed ID: 445398)
1. Leukocyte migration inhibition in vitro in bladder carcinoma.
Lavergne JA; Lamm DL; Radwin HM; Harrington JT
Cancer Res; 1979 Jun; 39(6 Pt 1):1985-8. PubMed ID: 445398
[TBL] [Abstract][Full Text] [Related]
2. Transitional cell carcinoma: circulating tumor antigen correlated with presence/absence of tumor (leukocyte migration assay).
Bowen JG
Natl Cancer Inst Monogr; 1978 Dec; (49):245-7. PubMed ID: 748778
[TBL] [Abstract][Full Text] [Related]
3. Leukocyte migration inhibition assay in patients with bladder cancer.
Schellhammer PF; Wright GL; Rosato FE; Faulconer RJ
J Urol; 1979 Dec; 122(6):746-9. PubMed ID: 513216
[TBL] [Abstract][Full Text] [Related]
4. [Suppression of leukocyte migration in bladder cancer with tumor antigens before and after surgery].
Borisenko ID; Novikov DK; Shein IA
Urol Nefrol (Mosk); 1978; (2):26-9. PubMed ID: 644715
[No Abstract] [Full Text] [Related]
5. Some uses and limitations of immunologic testing in human patients.
Lavergne JA
Bol Asoc Med P R; 1981 Apr; 73(4):141-5. PubMed ID: 6946780
[No Abstract] [Full Text] [Related]
6. Indirect macrophage migration inhibition response to 3-M KCl extract of gastric carcinoma.
Akiyoshi T; Koba F; Kawaguchi M; Miyazaki S; Tsuji H
J Natl Cancer Inst; 1982 Aug; 69(2):345-7. PubMed ID: 6955541
[TBL] [Abstract][Full Text] [Related]
7. Skin tests with soluble tumor membrane antigens in patients with transitional cell cancers.
Hollinshead AC
Natl Cancer Inst Monogr; 1978 Dec; (49):255-6. PubMed ID: 748779
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of circulating cytotoxic lymphocytes against autologous tumors in patients with bladder cancer.
Mizutani Y; Okada Y; Terachi T; Yoshida O
J Urol; 1996 Mar; 155(3):888-92; discussion 892-4. PubMed ID: 8583600
[TBL] [Abstract][Full Text] [Related]
9. In vitro production of human antibodies against bladder cancer: characterization and diagnostic implications.
Pizza G; De Vinci C
J Exp Pathol; 1987; 3(4):335-46. PubMed ID: 2457663
[No Abstract] [Full Text] [Related]
10. [Cell immunity indices in carcinoma of the gastrointestinal tract].
Kurtenkov OA
Vopr Onkol; 1976; 22(10):14-8. PubMed ID: 1014487
[TBL] [Abstract][Full Text] [Related]
11. Depression of the generation of cell-mediated cytotoxicity by macrophage-like suppressor cells in bladder carcinoma patients.
Spina CA; Dorey F; Vescera C; Brosman S; Fahey JL
Cancer Res; 1981 Nov; 41(11 Pt 1):4324-30. PubMed ID: 6458353
[TBL] [Abstract][Full Text] [Related]
12. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
[TBL] [Abstract][Full Text] [Related]
13. [The study on Thomsen-Friedenreich antigen in bladder tumor].
Oda Y
Hinyokika Kiyo; 1985 Mar; 31(3):407-18. PubMed ID: 3895852
[TBL] [Abstract][Full Text] [Related]
14. [Effect of 3-hydroxyanthranilic acid-antigen on the migration of peripheral blood leukocytes in patients with bladder tumors].
Korosteleva TA; Kliucharev BV; Skadova VM; Vorob'ev AV; Chebotkevich VN
Vopr Onkol; 1987; 33(5):59-62. PubMed ID: 3296440
[TBL] [Abstract][Full Text] [Related]
15. Studies of the nonspecific cellular immune response in patients with urinary bladder carcinoma. II. Immunodepressive effect of sera from bladder carcinoma.
Nishio S; Horii A; Morikawa Y; Kawakita J; Nishijima T; Kishimoto T; Maekawa M
Invest Urol; 1979 Mar; 16(5):342-5. PubMed ID: 429128
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies against P53 protein in patients with transitional cell carcinoma of the bladder.
Sanchez-Carbayo M; Chulia MT; Niveiro M; Aranda I; Mira A; Soria F
Anticancer Res; 1999; 19(4C):3531-7. PubMed ID: 10629648
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of leukocyte migration by tumor-associated antigen in soluble extracts of human hepatoma.
Lee C; Chen S; Lin T
Cancer Res; 1977 Mar; 37(3):918-21. PubMed ID: 189919
[TBL] [Abstract][Full Text] [Related]
18. [Effect of the serum blocking factor assay in the diagnosis and treatment of bladder cancer].
Xu JN; Li YT; Zhang ZY
Zhonghua Wai Ke Za Zhi; 1985 Aug; 23(8):453-6, 508. PubMed ID: 4092537
[No Abstract] [Full Text] [Related]
19. [Studies on multiple mucosal biopsy in patients with bladder cancer. 4. Evaluation of Thomsen-Friedenreich antigen in multiple mucosal biopsy and transitional cell carcinoma of the bladder].
Igawa M
Hinyokika Kiyo; 1986 Nov; 32(11):1663-76. PubMed ID: 3825815
[TBL] [Abstract][Full Text] [Related]
20. [Monoclonal antibodies against transitional cell carcinoma assay tumor associated antigens in different grades bladder cancer patients].
Zhang H; Zhao Z; Sun H
Zhonghua Wai Ke Za Zhi; 1996 Sep; 34(9):560-2. PubMed ID: 9594163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
